| 51 |
33859780 | Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis. | 2021 |
3 |
| 52 |
33908630 | Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells. | 2021 Jun |
1 |
| 53 |
33960434 | Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells. | 2021 Sep |
1 |
| 54 |
34017375 | Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer. | 2021 |
1 |
| 55 |
34026767 | Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway. | 2021 |
1 |
| 56 |
34046349 | Down-Regulating the Expression of miRNA-21 Inhibits the Glucose Metabolism of A549/DDP Cells and Promotes Cell Death Through the PI3K/AKT/mTOR/HIF-1α Pathway. | 2021 |
2 |
| 57 |
34068624 | Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism. | 2021 May 10 |
1 |
| 58 |
34077013 | Apatinib strengthens the anti-tumor effect of cisplatin in thyroid carcinoma through downregulating VEGFR2. | 2021 Mar-Apr |
4 |
| 59 |
34077027 | Tormentic acid induces anticancer effects in cisplatin-resistant human cervical cancer cells mediated via cell cycle arrest, ROS production, and targeting mTOR/PI3K/AKT signalling pathway. | 2021 Mar-Apr |
2 |
| 60 |
34077275 | Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis. | 2021 Jun |
1 |
| 61 |
34096570 | MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway. | 2021 Dec 22 |
2 |
| 62 |
34230143 | Inhibition of AKT Enhances the Sensitivity of NSCLC Cells to Metformin. | 2021 Jul |
1 |
| 63 |
34261004 | Cisplatin's potential for type 2 diabetes repositioning by inhibiting CDKN1A, FAS, and SESN1. | 2021 Aug |
1 |
| 64 |
34266345 | MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route. | 2021 Dec |
1 |
| 65 |
34277602 | NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway. | 2021 |
2 |
| 66 |
34277781 | A novel peptide promotes human trophoblast proliferation and migration through PI3K/Akt/mTOR signaling pathway. | 2021 Jun |
1 |
| 67 |
34313895 | Silencing of ATG4D suppressed proliferation and enhanced cisplatin-induced apoptosis in hepatocellular carcinoma through Akt/Caspase-3 pathway. | 2021 Nov |
1 |
| 68 |
34427099 | HDAC3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway. | 2021 Sep |
1 |
| 69 |
34475767 | Daam1 Overexpression Promotes Gastric Cancer Progression and Regulates ERK and AKT Signaling Pathways. | 2021 |
1 |
| 70 |
34486197 | HGF/c-MET pathway contributes to cisplatin-mediated PD-L1 expression in hepatocellular carcinoma. | 2021 Dec |
3 |
| 71 |
34542810 | Nitrate increases cisplatin chemosensitivity of oral squamous cell carcinoma via REDD1/AKT signaling pathway. | 2021 Nov |
2 |
| 72 |
34585447 | Zeylenone synergizes with cisplatin in osteosarcoma by enhancing DNA damage, apoptosis, and necrosis via the Hsp90/AKT/GSK3β and Fanconi anaemia pathway. | 2021 Oct |
2 |
| 73 |
34598710 | TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer. | 2021 Oct 2 |
1 |
| 74 |
34638339 | Heat Shock Protein 27, a Novel Downstream Target of Collagen Type XI alpha 1, Synergizes with Fatty Acid Oxidation to Confer Cisplatin Resistance in Ovarian Cancer Cells. | 2021 Sep 28 |
1 |
| 75 |
34888594 | [Insight into the role of IGF2BP1 in drug resistant mechanism of oral squamous cell carcinoma]. | 2021 Oct |
2 |
| 76 |
34901018 | Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways. | 2021 |
1 |
| 77 |
34915755 | A nano based approach to alleviate cisplatin induced nephrotoxicity. | 2021 Jan-Dec |
1 |
| 78 |
34953496 | Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway. | 2021 Dec 25 |
1 |
| 79 |
34977076 | Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells via PI3K/Akt Pathway. | 2021 |
1 |
| 80 |
31267531 | microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer. | 2020 Feb |
3 |
| 81 |
31558183 | Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis. | 2020 Feb 7 |
3 |
| 82 |
31630149 | Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells. | 2020 |
1 |
| 83 |
31648572 | Radiosensitizing Potential of Curcumin in Different Cancer Models. | 2020 |
1 |
| 84 |
31742349 | Protective effects of human umbilical cord mesenchymal stem cell-derived conditioned medium on ovarian damage. | 2020 Jun 11 |
1 |
| 85 |
31843707 | Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy. | 2020 Mar |
1 |
| 86 |
31875760 | Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway. | 2020 Dec |
1 |
| 87 |
31885317 | The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells. | 2020 Nov |
4 |
| 88 |
31897216 | AFAP1-AS1 induces cisplatin resistance in non-small cell lung cancer through PI3K/AKT pathway. | 2020 Jan |
1 |
| 89 |
31905343 | Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter. | 2020 Jan 6 |
1 |
| 90 |
31913198 | miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. | 2020 Apr |
3 |
| 91 |
31983246 | Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling. | 2020 Nov |
1 |
| 92 |
32021259 | miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway. | 2020 |
2 |
| 93 |
32027070 | MicroRNA-31 weakens cisplatin resistance of medulloblastoma cells via NF-κB and PI3K/AKT pathways. | 2020 Sep |
1 |
| 94 |
32064052 | Correction: The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer. | 2020 Jan 28 |
1 |
| 95 |
32104214 | Ghrelin inhibits cisplatin-induced MDA-MB-231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling. | 2020 Mar |
3 |
| 96 |
32165307 | TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2. | 2020 Jul 15 |
1 |
| 97 |
32186774 | miR‑10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway. | 2020 Jun |
3 |
| 98 |
32222530 | Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K/Akt signaling pathway. | 2020 Jun 30 |
3 |
| 99 |
32277616 | Tormentic acid induces anticancer effects in cisplatin-resistant human cervical cancer cells mediated via cell cycle arrest, ROS production, and targeting mTOR/PI3K/AKT signalling pathway. | 2020 Jan-Feb |
2 |
| 100 |
32308421 | miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer. | 2020 |
1 |